Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 5 for Island Kinetics, Inc. d.b.a. CoValence Laboratories.
Island Kinetics, Inc. d.b.a. CoValence Laboratories: 1 warning letter, 4 recalls, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Side by side
Island Kinetics, Inc. d.b.a. CoValence Laboratories — Warning letters1
Philips North America — Warning letters0
Island Kinetics, Inc. d.b.a. CoValence Laboratories — Recalls4
Philips North America — Recalls355
Island Kinetics, Inc. d.b.a. CoValence Laboratories — Approval records0
Philips North America — Approval records0
Island Kinetics, Inc. d.b.a. CoValence Laboratories — Form 483s0
Philips North America — Form 483s0
Timeline
Island Kinetics, Inc. d.b.a. CoValence Laboratories
Most recent FDA action: July 16, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Island Kinetics, Inc. d.b.a. CoValence Laboratories vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/island-kinetics-inc-d-b-a-covalence-laboratories-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗